title: When oral anticoagulation therapy is needed in patients with cardiomyopathies: a review of literature.
abstract: The question whether to anticoagulate patients with cardiomyopathy or not is over 50 years old. Multiple clinical trials have demonstrated the superior therapeutic effect of warfarin compared with placebo in the prevention of thromboembolic events amongst patients with nonvalvular atrial fibrillation. The purpose of our work is to review literature about the role of anticoagulation in the main cardiomyopathies.
authors.affiliation: Section of Cardiovascular Diseases, Department of Experimental and Applied Medicine, University of Study of Brescia, Italy. enrico.vizzardi@tin.it
authors.forename: Enrico
authors.initials: E
authors.lastname: Vizzardi
authors.forename: Ivano
authors.initials: I
authors.lastname: Bonadei
authors.forename: Francesca
authors.initials: F
authors.lastname: Del Magro
authors.forename: Silvia
authors.initials: S
authors.lastname: Bugatti
authors.forename: Antonio
authors.initials: A
authors.lastname: D'Aloia
authors.forename: Antonio
authors.initials: A
authors.lastname: Curnis
authors.forename: Livio Dei
authors.initials: LD
authors.lastname: Cas
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage*; D009202:Cardiomyopathies / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants